Page last updated: 2024-08-17

cytidine and leflunomide

cytidine has been researched along with leflunomide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartlett, RR; Müller, S; Zeitter, D; Zielinski, T1
Collins, M; Graves, LM; Huang, M; Mitchell, BS; Wang, Y1
Collins, M; Graves, LM; Huang, M; Wang, Y1

Other Studies

3 other study(ies) available for cytidine and leflunomide

ArticleYear
Leflunomide, a reversible inhibitor of pyrimidine biosynthesis?
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1995, Volume: 44 Suppl 2

    Topics: Cell Division; Cell Line; Cytidine; Humans; Immunosuppressive Agents; Isoxazoles; Kinetics; Leflunomide; Pyrimidines; Uracil Nucleotides; Uridine

1995
A77 1726 induces differentiation of human myeloid leukemia K562 cells by depletion of intracellular CTP pools.
    Molecular pharmacology, 2002, Volume: 62, Issue:3

    Topics: Aniline Compounds; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Carbamoyltransferase; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cell Cycle Proteins; Cell Differentiation; Cell Division; Crotonates; Cytidine; Cytidine Triphosphate; Dihydroorotase; Drug Interactions; Gene Expression; Glycophorins; Humans; Hydroxybutyrates; Isoxazoles; K562 Cells; Leflunomide; Multienzyme Complexes; Nitriles; Pyrimidines; S Phase; Toluidines; Uridine; Uridine Triphosphate

2002
CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.
    Leukemia, 2004, Volume: 18, Issue:11

    Topics: Affinity Labels; Carbon-Nitrogen Ligases; Cell Differentiation; Cytidine; Cytidine Triphosphate; Dipyridamole; Enzyme Inhibitors; Equilibrative Nucleoside Transporter 1; Erythroid Precursor Cells; Humans; Isoxazoles; K562 Cells; Leflunomide; Leukemia, Myeloid; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Pyrimidines; RNA, Small Interfering; S Phase; Thioinosine

2004